Annual Cash & Cash Equivalents
$35.49 M
-$4.96 M-12.27%
December 31, 2023
Summary
- As of February 8, 2025, KZR annual cash & cash equivalents is $35.49 million, with the most recent change of -$4.96 million (-12.27%) on December 31, 2023.
- During the last 3 years, KZR annual cash & cash equivalents has risen by +$14.27 million (+67.20%).
- KZR annual cash & cash equivalents is now -43.56% below its all-time high of $62.88 million, reached on December 31, 2021.
Performance
KZR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$34.86 M
+$6.58 M+23.28%
September 30, 2024
Summary
- As of February 8, 2025, KZR quarterly cash and cash equivalents is $34.86 million, with the most recent change of +$6.58 million (+23.28%) on September 30, 2024.
- Over the past year, KZR quarterly cash and cash equivalents has stayed the same.
- KZR quarterly cash and cash equivalents is now -66.92% below its all-time high of $105.39 million, reached on June 30, 2022.
Performance
KZR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
KZR Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -12.3% | 0.0% |
3 y3 years | +67.2% | 0.0% |
5 y5 years | +46.8% | 0.0% |
KZR Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -43.6% | at low | -66.9% | +31.6% |
5 y | 5-year | -43.6% | +137.4% | -66.9% | +171.6% |
alltime | all time | -43.6% | +264.1% | -66.9% | +171.6% |
Kezar Life Sciences Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $34.86 M(+23.3%) |
Jun 2024 | - | $28.28 M(-14.4%) |
Mar 2024 | - | $33.03 M(-6.9%) |
Dec 2023 | $35.49 M(-12.3%) | $35.49 M(+33.9%) |
Sep 2023 | - | $26.50 M(-5.7%) |
Jun 2023 | - | $28.11 M(-22.2%) |
Mar 2023 | - | $36.13 M(-10.7%) |
Dec 2022 | $40.46 M(-35.7%) | $40.46 M(-37.2%) |
Sep 2022 | - | $64.45 M(-38.8%) |
Jun 2022 | - | $105.39 M(+170.9%) |
Mar 2022 | - | $38.91 M(-38.1%) |
Dec 2021 | $62.88 M | $62.88 M(+10.1%) |
Sep 2021 | - | $57.09 M(+116.4%) |
Jun 2021 | - | $26.38 M(+15.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $22.91 M(+7.9%) |
Dec 2020 | $21.23 M(+42.0%) | $21.23 M(+65.4%) |
Sep 2020 | - | $12.83 M(-25.8%) |
Jun 2020 | - | $17.30 M(-15.9%) |
Mar 2020 | - | $20.57 M(+37.6%) |
Dec 2019 | $14.95 M(-38.2%) | $14.95 M(-26.6%) |
Sep 2019 | - | $20.36 M(+56.3%) |
Jun 2019 | - | $13.03 M(-29.4%) |
Mar 2019 | - | $18.47 M(-23.6%) |
Dec 2018 | $24.18 M(-52.6%) | $24.18 M(-38.9%) |
Sep 2018 | - | $39.59 M(-61.2%) |
Jun 2018 | - | $101.97 M(+116.6%) |
Mar 2018 | - | $47.09 M(-7.7%) |
Dec 2017 | $51.03 M(+423.6%) | $51.03 M |
Dec 2016 | $9.75 M | - |
FAQ
- What is Kezar Life Sciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Kezar Life Sciences?
- What is Kezar Life Sciences annual cash & cash equivalents year-on-year change?
- What is Kezar Life Sciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Kezar Life Sciences?
- What is Kezar Life Sciences quarterly cash and cash equivalents year-on-year change?
What is Kezar Life Sciences annual cash & cash equivalents?
The current annual cash & cash equivalents of KZR is $35.49 M
What is the all time high annual cash & cash equivalents for Kezar Life Sciences?
Kezar Life Sciences all-time high annual cash & cash equivalents is $62.88 M
What is Kezar Life Sciences annual cash & cash equivalents year-on-year change?
Over the past year, KZR annual cash & cash equivalents has changed by -$4.96 M (-12.27%)
What is Kezar Life Sciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of KZR is $34.86 M
What is the all time high quarterly cash and cash equivalents for Kezar Life Sciences?
Kezar Life Sciences all-time high quarterly cash and cash equivalents is $105.39 M
What is Kezar Life Sciences quarterly cash and cash equivalents year-on-year change?
Over the past year, KZR quarterly cash and cash equivalents has changed by $0.00 (0.00%)